Perceptual Disorders: Clinical Trials

268 trials for Perceptual Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

139 completed, 52 unknown, 25 recruiting, 24 terminated. 268 Phase 3, 52 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3268Completed 139, Unknown 52, Recruiting 25, Terminated 24, Withdrawn 11, Active not recruiting 5, Not yet recruiting 5, Suspended 4, Enrolling by invitation 3
Phase 252Completed 29, Unknown 10, Terminated 4, Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Suspended 1, Withdrawn 1

Follow Perceptual Disorders: new trials by email Literature Review of Perceptual Disorders trials Research Report on Perceptual Disorders

Trials (filtered) newest first · largest first

All 268 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine for Invasive Ventilation In the NEOnate
Dexmedetomidine Injectable Solution, Glucose 5% Injectable Solution - Invasive Ventilation, Infant Pain
Phase 2 / Phase 3Not yet recruitingCentre Hospitalier Intercommunal Creteil2462027-01-012026-08-26
Safety of F14 Following Total Knee Replacement
F14 (sustained release celecoxib) - Analgesia
Phase 2 / Phase 3SuspendedArthritis Innovation Corporation1002027-01-012026-06-05
Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric Surgery
Tegileridine (tegileridine fumarate injection, IV), Sufentanil - Pain Management, Overweight , Obesity
Phase 3RecruitingThe First Hospital of Jilin University1482026-10-282026-11-03
Morphine or Ketamine for Analgesia
Ketamine hydrochloride, Morphine sulphate - Abdominal Pain, Isolated Extremity Fracture
Phase 3RecruitingColumbia University10102026-10-172026-10-20
Suzetrigine in TKA
Placebo, Suzetrigine - Total Knee Arthroplasty (TKA), Total Knee Arthroplasty \(TKA\)
Phase 3RecruitingHospital for Special Surgery, New York1482026-10-152026-10-13
Methoxyflurane Versus Usual Care for Non-Traumatic Pain in Emergency Departments
Analgesic management with Methoxyflurane as first-line treatment, Pain treatment according to the usual analgesic management protocol of the emergency department of the participating center. - Pain Management
Phase 3Not yet recruitingUniversity Hospital, Tours1642026-09-162026-08-03
Echo-guided Scalp Blocks and Incidence of Postoperative Pain in Scheduled Supratentorial Intracranial Surgery.
Echo-guided scalp blocks, Classic anesthetic strategy - Anesthesia , Analgesia
Phase 3Not yet recruitingUniversity Hospital, Bordeaux2302026-09-012026-08-07
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
Lidocain, Placebo, Standard of care - Vaso-Occlusive Pain Episode in Sickle Cell Disease
Phase 3RecruitingNantes University Hospital1042026-07-032026-09-09
Influence of Superficial Parasternal Intercostal Plane Block on Internal Thoracic Artery Caliber to Facilitate Surgical Harvesting in CABG
Bupivacaine - Pain Management, Parasternal Block
Phase 3RecruitingAin Shams University502026-07-012026-10-28
Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients
oral ketamine, oxycodone - Pain Management
Phase 2 / Phase 3Not yet recruitingAlbany Medical College602026-06-242026-06-26
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations
Safinamide, Placebo - PARKINSON DISEASE (Disorder), Pain
Phase 3RecruitingUniversita di Verona602026-04-282026-08-13
The Effect of Lactoferrin on Pain Management Following Cesarean Section
Lactoferrin, Placebo - Cesarean Birth, Post Operative Analgesia
Phase 3Not yet recruitingAin Shams University902026-03-262026-03-30
Opioid-Sparing Joint Replacement
Placebo, Oxycodone 5 mg, Multimodal Non-Opioid Analgesia - Pain Management, Opioid Consumption
Phase 3RecruitingEmory University1202026-03-192026-04-17
Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip Surgeries
Bupivacaine - Pain Management
Phase 3RecruitingBenha University902026-03-152026-10-16
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
IM ketamine in dose finding and then continuation - Phantom Limb Syndrome With Pain
Phase 2 / Phase 3RecruitingThe Ketamine Research Foundation302026-01-152026-03-18
Optimizing Pain Treatment in Children On Mechanical Ventilation
Acetaminophen, Ketorolac, Placebo - Mechanical Ventilation, Pediatric Acute Respiratory Failure
Phase 3RecruitingWeill Medical College of Cornell University6442025-12-292026-10-29
Efficacy of EXPAREL vs. Bupivacaine
EXPAREL, 0.25% bupivacaine (HCl): 50 ml, 0.25% bupivacaine (HCl): 30 ml - Total Ankle Arthroplasty, Postsurgical Analgesia
Phase 3RecruitingEmory University1042025-11-172026-02-23
R.E.C.K vs Exparel in Robotic Nephrectomy
Ropivacaine HCL, Exparel, Epinephrine - Renal Carcinoma, Nephrectomy / Methods
Phase 3RecruitingWake Forest University Health Sciences1702025-11-142026-07-13
Suzetrigine in Total Hip Arthroplasty
Suzetrigine, Placebo - Total Hip Arthroplasty (THA), Total Hip Arthroplasty \(THA\)
Phase 3RecruitingHospital for Special Surgery, New York2102025-11-032026-07-30
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
Ketamine + Lidocaine, Ketamine group, Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray) - Distal Radius Fracture Reduction, Pain Control
Phase 3RecruitingState University of New York at Buffalo502025-08-222025-10-10

Showing 20 of 268. Sign in to see all of them.

Narrower conditions

Agnosia (254)  ·  Pain (66)  ·  Pain, Postoperative (59)  ·  Chronic Pain (12)  ·  Marijuana Abuse (10)  ·  Phantom Limb (9)  ·  Hallucinations (8)  ·  Somatoform Disorders (8)  ·  Acute Pain (7)  ·  Neuralgia (7)  ·  Osteoarthritis (5)  ·  Anemia, Sickle Cell (4)  ·  Breast Neoplasms (4)  ·  Delusions (4)  ·  Emergencies (4)

Broader conditions

Neurobehavioral Manifestations (268)  ·  Neurologic Manifestations (268)  ·  Pathological Conditions, Signs and Symptoms (268)  ·  Signs and Symptoms (268)  ·  Nervous System Diseases (267)  ·  Pathologic Processes (77)  ·  Postoperative Complications (66)  ·  Pain (64)  ·  Mental Disorders (24)  ·  Musculoskeletal Diseases (18)  ·  Chemically-Induced Disorders (16)  ·  Neoplasms (14)  ·  Wounds and Injuries (14)  ·  Neoplasms by Site (13)

Interventions

Bupivacaine (25)  ·  Sodium Chloride (18)  ·  Acetaminophen (16)  ·  Dexmedetomidine (16)  ·  Ketamine (15)  ·  Morphine (15)  ·  Ropivacaine (14)  ·  Fentanyl (13)  ·  Ibuprofen (13)  ·  Saline Solution (12)  ·  Oxycodone (11)  ·  Lidocaine (10)  ·  Dexamethasone (9)  ·  Analgesics, Opioid (7)  ·  Epinephrine (7)

Sponsors

Apurano Pharmaceuticals GmbH (8)  ·  Assiut University (8)  ·  Ain Shams University (7)  ·  Pacira Pharmaceuticals, Inc (6)  ·  University of Toronto (6)  ·  Baudax Bio (5)  ·  Stanford University (4)  ·  University Hospital, Bordeaux (4)  ·  ACADIA Pharmaceuticals Inc. (3)  ·  Avenue Therapeutics, Inc. (3)  ·  Emory University (3)  ·  Hadassah Medical Organization (3)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (3)  ·  Nantes University Hospital (3)  ·  Shaare Zedek Medical Center (3)

Countries

United States (91)  ·  Canada (26)  ·  France (26)  ·  Egypt (18)  ·  Germany (14)  ·  Brazil (10)  ·  China (9)  ·  Italy (8)  ·  Israel (7)  ·  Denmark (6)  ·  Spain (6)  ·  Belgium (5)  ·  Colombia (5)  ·  Czechia (5)  ·  Norway (5)

Top investigators

Anna Taddio, PhD (7)  ·  Anne Arriaga (2)  ·  Gary Nevins (2)  ·  Menachem Oberbaum, M.D. (2)  ·  Yang Yi, MD (2)  ·  Abdelwahab Saleh (1)  ·  Abeer A Alshami, PhD (1)  ·  Adel Guirguis, MD, MS (1)  ·  Ahmad M Abd El-Rahman, M.D. (1)  ·  Aida R Tantri, MD (1)  ·  Ajay Premkumar, MD (1)  ·  Alex D Mitchell, MD (1)

Results publications

PMID 22900785, PMID 30737315, PMID 12873949, PMID 14995921, PMID 1517644, PMID 15197122, PMID 15562083, PMID 15659468, PMID 15919269, PMID 16478902, PMID 16492849, PMID 16521220, PMID 17138198, PMID 17242082, PMID 17341537, PMID 17464603, PMID 18042413, PMID 18191686, PMID 18292452, PMID 18388680, PMID 19050084, PMID 19224805, PMID 19948613, PMID 20012652, PMID 20384968, PMID 21368651, PMID 21436683, PMID 21471025, PMID 21494892, PMID 21561303, PMID 21562445, PMID 21621130, PMID 21765198, PMID 21788309, PMID 21818576, PMID 22013534, PMID 22112332, PMID 22227789, PMID 22402535, PMID 22419342, PMID 22535806, PMID 23049275, PMID 23223119, PMID 23516031, PMID 23611363, PMID 24054878, PMID 24353022, PMID 24399578, PMID 24634424, PMID 24659334

NIH funding

2019 (3), 2014 (2), 2015 (2), 2025 (2), 2004 (1), 2008 (1), 2009 (1), 2017 (1), 2018 (1), 2023 (1), 5UH3DE028860-05 (1), P30CA012197 (1), R01AT000004 (1), R01DA030424 (1), U01HD116253 (1)